Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma in Situ
Description
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. MeSH
Hierarchy View
Subtype Terms (4)
Adenocarcinoma in Situ
2 approved drugs
Breast Carcinoma In Situ
12 drugs (11 approved, 1 experimental)
Cervical Intraepithelial Neoplasia
49 drugs (24 approved, 25 experimental)
Prostatic Intraepithelial Neoplasia
5 drugs (1 approved, 4 experimental)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (57)
Academic and Community Cancer Research United
Associazione Italiana per la Ricerca sul Cancro
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Cancer and Leukemia Group B (CALGB)
Chinese Academy of Medical Sciences
Ente Ospedaliero Ospedali Galliera
International Breast Cancer Study Group
Organization Involved with Phase 2 Indications (81)
AIDS and Cancer Specimen Resource
Center for Clinical and Cosmetic Research
Cheil General Hospital & Women's Healthcare Center
Gottfried Wilhelm Leibniz Universität Hannover
Kharkov Academy of Postgraduate Education
Lyndhurst Gynecologic Associates
North Estonia Medical Centre Foundation
Odessa National Medical University
Oregon Health and Science University
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
